Journal of General and Family Medicine (May 2021)

Seroprevalence of SARS‐CoV‐2 in Utsunomiya City, Greater Tokyo, after the first pandemic in 2020

  • Nobutoshi Nawa,
  • Jin Kuramochi,
  • Shiro Sonoda,
  • Yui Yamaoka,
  • Yoko Nukui,
  • Yasunari Miyazaki,
  • Takeo Fujiwara

DOI
https://doi.org/10.1002/jgf2.408
Journal volume & issue
Vol. 22, no. 3
pp. 160 – 162

Abstract

Read online

Abstract Background A seroepidemiological study was conducted on a random sample of households in Utsunomiya City, Tochigi Prefecture, Greater Tokyo, Japan, to assess the seroprevalence of SARS‐CoV‐2. Methods The level of IgG antibodies in the blood of the recruited subjects was assessed using chemiluminescence immunoassay analysis. In addition, the population‐based prevalence of SARS‐CoV‐2 was estimated. Results Three positive afebrile cases were confirmed. The estimated unweighted prevalence and weighted prevalence of SARS‐CoV‐2 infection were 0.40% and 1.23%, respectively. Conclusions This study suggests that the prevalence of SARS‐CoV‐2 may have been underestimated. Wider testing strategies may lead to revealing more SARS‐CoV‐2 cases.

Keywords